Disorders associated with reduced gastrointestinal motility
Adult: As anhydrous citrate: 5 mg tid.
Indications and Dosage
Oral
Disorders associated with reduced gastrointestinal motility Adult: As anhydrous citrate: 5 mg tid.
|
Special Precautions
Continuous admin of this drug is not recommended if no improvement in GI symptoms is observed after 2 wk of admin. Elderly, renal impairment, hepatic impairment.
|
Adverse Reactions
Diarrhoea, abdominal pain; dizziness; constipation; headache; insomnia; nausea.
|
Drug Interactions
Mosapride concentration increased by erythromycin. May increase risk of QT prolongation with QT prolonging drugs.
|
Action
Description:
Mechanism of Action: Mosapride is a 5-HT4 receptor agonist which increases the release of acetylcholine and stimulates GI motility. It also has 5-HT3 antagonist properties. |